Choctaw Regional Medical Center
Choctaw Regional Medical Center was paid $4.94M by Medicaid between Jan 2018 and Nov 2024, across 91 billing codes. Its largest line is 90853, Group psychotherapy (other than of a multiple-family group) — 33% of everything it billed.
33Billing provider infoCHOCTAW REGIONAL MEDICAL CENTER
ACKERMAN, MS 39735
ACKERMAN, MS 39735
33aNPI1568879864assigned 07/18/2014
33bProvider typePersonal Emergency Response Attendant
28Total paid$4.94M
24GClaims143,738
24DCodes billed91
24AFirst – last monthJan 2018 – Nov 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,218 | $873K | |
| 2019 | 25,097 | $911K | |
| 2020 | 17,476 | $511K | |
| 2021 | 20,921 | $675K | |
| 2022 | 21,948 | $726K | |
| 2023 | 16,940 | $757K | |
| 2024incomplete | 15,138 | $480K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90853 | Group psychotherapy (other than of a multiple-family group) | 33% | 11,261 | 1,014 | $1.62M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 7,815 | 5,154 | $539K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.8% | 3,379 | 1,774 | $437K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 5.6% | 3,427 | 2,047 | $277K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.5% | 4,774 | 3,363 | $270K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.8% | 5,322 | 4,128 | $190K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 2.6% | 1,054 | 990 | $126K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.4% | 1,685 | 1,243 | $116K |
| 71046 | Radiologic examination, chest; 2 views | 2.1% | 3,066 | 2,275 | $105K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 2,856 | 2,052 | $101K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.9% | 7,287 | 6,125 | $92K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 1.8% | 6,714 | 501 | $87K |
79 more codes
| 71045 | Radiologic examination, chest; single view | 1.6% | 2,366 | $77K |
| 94799 | 1.5% | 1,496 | $76K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 14,271 | $74K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.5% | 1,129 | $73K |
| 80053 | Comprehensive metabolic panel | 1.4% | 10,309 | $70K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 2,068 | $62K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 5,142 | $58K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,664 | $49K |
| 87428 | <1% | 1,220 | $48K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 605 | $47K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,809 | $33K |
| 87430 | <1% | 3,130 | $32K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,184 | $31K |
| 36415 | Collection of venous blood by venipuncture | <1% | 12,372 | $26K |
| 80061 | Lipid panel | <1% | 2,277 | $22K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 254 | $20K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 628 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,710 | $18K |
| 81025 | <1% | 2,066 | $12K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,719 | $11K |
| 81001 | <1% | 5,664 | $10K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 48 | $10K |
| 87807 | <1% | 797 | $8K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 89 | $8K |
| 83880 | <1% | 401 | $8K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 53 | $7K |
| 84484 | <1% | 945 | $7K | |
| 80305 | <1% | 858 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 862 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,668 | $4K |
| 74018 | <1% | 98 | $4K | |
| 73562 | <1% | 108 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 182 | $3K |
| 73630 | <1% | 89 | $3K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 43 | $2K |
| 82550 | <1% | 349 | $2K | |
| 82553 | <1% | 396 | $2K | |
| 94664 | <1% | 226 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 20 | $2K |
| Q3014 | Telehealth originating site facility fee | <1% | 117 | $1K |
| 82043 | <1% | 327 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,408 | $1K |
| 81000 | <1% | 390 | $1K | |
| 71250 | <1% | 12 | $1K | |
| 86677 | <1% | 103 | $938.60 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 15 | $808.02 |
| 97032 | <1% | 79 | $789.45 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 149 | $759.74 |
| 72100 | <1% | 15 | $716.88 | |
| 87070 | <1% | 118 | $715.57 | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 57 | $689.02 |
| 0012A | <1% | 47 | $665.31 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 169 | $632.04 |
| 87186 | <1% | 90 | $594.21 | |
| 83735 | <1% | 164 | $559.27 | |
| 81003 | <1% | 267 | $482.78 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $435.96 |
| 87081 | <1% | 59 | $418.96 | |
| 81002 | <1% | 174 | $336.69 | |
| 83690 | <1% | 69 | $243.64 | |
| 87205 | <1% | 86 | $241.50 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 12 | $235.37 |
| 83655 | <1% | 17 | $219.78 | |
| 0011A | <1% | 46 | $215.49 | |
| 82962 | <1% | 94 | $212.40 | |
| 94760 | <1% | 84 | $174.81 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 100 | $166.21 |
| 93000 | <1% | 19 | $141.96 | |
| 87210 | <1% | 34 | $103.82 | |
| 85379 | <1% | 18 | $88.60 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 82 | $58.56 |
| 86140 | <1% | 14 | $55.92 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 95 | $6.00 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | 0% | 32 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 23 | $0.00 |
| 84145 | 0% | 14 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 25 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 49 | $0.00 |
| 91301 | 0% | 96 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHOLLINGSWORTH WELLS, SUSAN (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Choctaw Regional Medical Center | Louisville, MS | $1.61M |
| Choctaw Regional Medical Center | Ackerman, MS | $1.16M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.